Neuren Pharmaceuticals Limited (ASX:NEU)
Australia flag Australia · Delayed Price · Currency is AUD
20.48
+0.50 (2.50%)
Sep 5, 2025, 4:10 PM AEST

Neuren Pharmaceuticals Ratios and Metrics

Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
2,5861,5883,1781,001475147
Upgrade
Market Cap Growth
-35.39%-50.04%217.33%110.87%222.46%-40.72%
Upgrade
Enterprise Value
2,2871,3743,092970457138
Upgrade
Last Close Price
20.4812.5024.977.953.771.28
Upgrade
PE Ratio
17.8411.1820.235442.54--
Upgrade
Forward PE
67.1919.4532.2019.55--
Upgrade
PS Ratio
11.827.3213.7064.96148.54205.40
Upgrade
PB Ratio
8.004.3615.4924.0812.106.09
Upgrade
P/TBV Ratio
8.004.3615.4924.0812.106.09
Upgrade
P/FCF Ratio
18.80-17.19279.73--
Upgrade
P/OCF Ratio
18.80-17.18278.25--
Upgrade
EV/Sales Ratio
10.456.3413.3362.94142.84192.61
Upgrade
EV/EBITDA Ratio
12.427.6715.52---
Upgrade
EV/EBIT Ratio
12.427.6715.52---
Upgrade
EV/FCF Ratio
16.62-16.73271.04--
Upgrade
Asset Turnover
0.780.661.590.370.100.04
Upgrade
Quick Ratio
40.428.695.6824.5947.5833.13
Upgrade
Current Ratio
40.428.735.7825.7749.8733.13
Upgrade
Return on Equity (ROE)
54.96%49.92%127.30%0.46%-24.57%-48.32%
Upgrade
Return on Assets (ROA)
41.13%34.05%85.52%-1.10%-15.83%-27.98%
Upgrade
Return on Capital (ROIC)
42.42%39.35%100.92%-1.13%-16.22%-28.94%
Upgrade
Return on Capital Employed (ROCE)
56.90%49.20%97.10%---
Upgrade
Earnings Yield
5.76%8.95%4.94%0.02%-1.64%-6.24%
Upgrade
FCF Yield
5.32%-0.71%5.82%0.36%-2.10%-5.49%
Upgrade
Buyback Yield / Dilution
0.98%-0.01%-1.44%-8.76%-10.71%-6.88%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.